Why 2026 is the Year Innovation Decouples in the China Biopharmaceuticals Market The landscape of biological medicine is reaching a historic inflection point this year as domestic capabilities shift from imitation to global leadership. In 2026, the China Biopharmaceuticals Market is projected to generate over 18 billion dollars in revenue, driven by a structural transition toward original, first-in-class therapies. This year marks "Day Zero" for a new era of self-reliance,...